Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph S Ross

Showing results (91-100 of 800) with videos related to

Pageof 80
Sort By:
JAMA|November 9, 2017
Pediatric Exclusivity and Regulatory Authority: Implications of Amgen v HHSJeanie Kim, Joseph S Ross, Amy Kapczynski
JAMA|November 14, 2017
High Costs of FDA Approval for Formerly Unapproved Marketed DrugsAaron Hakim, Ravi Gupta, Joseph S Ross
JAMA|March 20, 2024
Implications for Public Health Regulation if Chevron Deference Is OverturnedSahil Agrawal, Joseph S Ross, Reshma Ramachandran
BMJ (Clinical Research Ed.)|October 1, 2016
Authors' reply to RamachandranWilliam Fleischman, Joseph S Ross, Shantanu Agrawal
Plos One|October 30, 2024
Adoption of the voluntary conflict of interest statement on PubMedStephanie Rogus, Joseph S Ross, Peter Lurie
Journal of General Internal Medicine|February 28, 2018
Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA GuidelinesKristina Klara, Jeanie Kim, Joseph S Ross
BMJ (Clinical Research Ed.)|May 21, 2024
Tackling the excesses of pharmaceutical marketing and promotionRavi Gupta, Reshma Ramachandran, Joseph S Ross
JAMA Network Open|October 26, 2020
Transparency and Accountability of Medicaid Section 1115 Waiver Demonstration Programs Under the Affordable Care ActLeo Lopez, David Silvestri, Joseph S Ross
The American Journal of Medicine|September 30, 2009
Appropriateness of collaborations between industry and the medical profession: physicians' perceptionsJoseph S Ross, Salomeh Keyhani, Deborah Korenstein
Journal of General Internal Medicine|November 27, 2012
A measure of care coordination?Julie P W Bynum, Joseph S Ross
Pageof 80

Showing results (91-100 of 800) with videos related to

Sort By:
Pageof 80
JAMA|November 9, 2017
Pediatric Exclusivity and Regulatory Authority: Implications of Amgen v HHSJeanie Kim, Joseph S Ross, Amy Kapczynski
JAMA|November 14, 2017
High Costs of FDA Approval for Formerly Unapproved Marketed DrugsAaron Hakim, Ravi Gupta, Joseph S Ross
JAMA|March 20, 2024
Implications for Public Health Regulation if Chevron Deference Is OverturnedSahil Agrawal, Joseph S Ross, Reshma Ramachandran
BMJ (Clinical Research Ed.)|October 1, 2016
Authors' reply to RamachandranWilliam Fleischman, Joseph S Ross, Shantanu Agrawal
Plos One|October 30, 2024
Adoption of the voluntary conflict of interest statement on PubMedStephanie Rogus, Joseph S Ross, Peter Lurie
Journal of General Internal Medicine|February 28, 2018
Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA GuidelinesKristina Klara, Jeanie Kim, Joseph S Ross
BMJ (Clinical Research Ed.)|May 21, 2024
Tackling the excesses of pharmaceutical marketing and promotionRavi Gupta, Reshma Ramachandran, Joseph S Ross
JAMA Network Open|October 26, 2020
Transparency and Accountability of Medicaid Section 1115 Waiver Demonstration Programs Under the Affordable Care ActLeo Lopez, David Silvestri, Joseph S Ross
The American Journal of Medicine|September 30, 2009
Appropriateness of collaborations between industry and the medical profession: physicians' perceptionsJoseph S Ross, Salomeh Keyhani, Deborah Korenstein
Journal of General Internal Medicine|November 27, 2012
A measure of care coordination?Julie P W Bynum, Joseph S Ross
Pageof 80